These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 18672309

  • 21. Insulin aspart: a review.
    Owens D, Vora J.
    Expert Opin Drug Metab Toxicol; 2006 Oct; 2(5):793-804. PubMed ID: 17014395
    [Abstract] [Full Text] [Related]

  • 22. Repaglinide plus single-dose insulin glargine: a safe regimen for low-risk type 2 diabetic patients who insist on fasting in Ramadan.
    Bakiner O, Ertorer ME, Bozkirli E, Tutuncu NB, Demirag NG.
    Acta Diabetol; 2009 Mar; 46(1):63-5. PubMed ID: 18825302
    [Abstract] [Full Text] [Related]

  • 23. Targeting postprandial hyperglycaemia in patients with recently diagnosed type 2 diabetes with a fixed, weight-based dose of insulin Aspart.
    Gredal C, Rosenfalck AM, Dejgaard A, Hilsted J.
    Scand J Clin Lab Invest; 2008 Mar; 68(8):739-44. PubMed ID: 19016075
    [Abstract] [Full Text] [Related]

  • 24. The IMPROVE study--a multinational, observational study in type 2 diabetes: data from the Polish cohort.
    Gumprecht J, Zurawska G, Wolnik B, Dzida G.
    Endokrynol Pol; 2008 Mar; 59(6):460-6. PubMed ID: 19347809
    [Abstract] [Full Text] [Related]

  • 25. Comparison of glycaemic control in patients with Type 2 diabetes on basal insulin and fixed combination oral antidiabetic treatment: results of a pilot study.
    De Mattia G, Laurenti O, Moretti A.
    Acta Diabetol; 2009 Mar; 46(1):67-73. PubMed ID: 19030772
    [Abstract] [Full Text] [Related]

  • 26. Impact of therapeutic advances on hypoglycaemia in type 2 diabetes.
    Boyle PJ, Zrebiec J.
    Diabetes Metab Res Rev; 2008 Mar; 24(4):257-85. PubMed ID: 18232062
    [Abstract] [Full Text] [Related]

  • 27. Type 2 diabetes in primary care in belgium: need for structured shared care.
    Goderis G, Borgermans L, Heyrman J, Broeke CV, Grol R, Boland B, Mathieu C.
    Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):367-72. PubMed ID: 19358093
    [Abstract] [Full Text] [Related]

  • 28. Suggested insulin regimens for patients with type 1 diabetes mellitus who wish to fast during the month of Ramadan.
    Kobeissy A, Zantout MS, Azar ST.
    Clin Ther; 2008 Aug; 30(8):1408-15. PubMed ID: 18803984
    [Abstract] [Full Text] [Related]

  • 29. [Hypertension and insulin treatment in type 2 diabetes].
    Ben Salem Hachmi L, Bouguerra R, Maatki O, Smadhi H, Turki Z, Hraoui S, Ben Slama C.
    Arch Mal Coeur Vaiss; 2007 Aug; 100(8):664-7. PubMed ID: 17928772
    [Abstract] [Full Text] [Related]

  • 30. Switching patients from insulin glargine-based basal-bolus regimens to a once daily insulin detemir-based basal-bolus regimen: results from a subgroup of the PREDICTIVE study.
    Yenigun M, Honka M.
    Int J Clin Pract; 2009 Mar; 63(3):425-32. PubMed ID: 19222627
    [Abstract] [Full Text] [Related]

  • 31. Assessment of quality of life in patients with type 2 diabetes mellitus before and after starting biphasic insulin aspart 30 (BIAsp 30) therapy: IMPROVE study in Japan.
    Ishii H, Iwase M, Seino H, Shuto Y, Atsumi Y.
    Curr Med Res Opin; 2011 Mar; 27(3):643-50. PubMed ID: 21250861
    [Abstract] [Full Text] [Related]

  • 32. The role of new basal insulin analogues in the initiation and optimisation of insulin therapy in type 2 diabetes.
    Baxter MA.
    Acta Diabetol; 2008 Dec; 45(4):253-68. PubMed ID: 18766296
    [Abstract] [Full Text] [Related]

  • 33. Assessment of the efficacy and tolerability of a fixed dose combination of atorvastatin 10 mg + metformin SR 500 mg in diabetic dyslipidaemia in adult Indian patients.
    Balasubramanian R, Varadharajan S, Kathale A, Nagraj LM, Periyandavar I, Nayak UP, Sharma A, Bolmall C, Baliga VP.
    J Indian Med Assoc; 2008 Jul; 106(7):464-7. PubMed ID: 18975505
    [Abstract] [Full Text] [Related]

  • 34. [Evaluating the feature of hypoglycemia detected by continuous glucose monitoring system during temporary continuous subcutaneous insulin infusion in type 2 diabetes patients].
    Li M, Zhou J, Bo YQ, Lu W, Jia WP, Xiang KS.
    Zhonghua Yi Xue Za Zhi; 2008 Jun 24; 88(24):1679-82. PubMed ID: 19024537
    [Abstract] [Full Text] [Related]

  • 35. Tolerability outcomes of a multicenter, observational, open-label, drug-surveillance study in patients with type 2 diabetes mellitus treated with pioglitazone for 2 years.
    Grossman LD, Parlan G, Bailey AL, Yee G, Yu M, Chan JY.
    Clin Ther; 2009 Jan 24; 31(1):74-88. PubMed ID: 19243708
    [Abstract] [Full Text] [Related]

  • 36. Nocturnal hypoglycaemia in type 1 diabetes--consequences and assessment.
    DeVries JH, Wentholt IM, Masurel N, Mantel I, Poscia A, Maran A, Heine RJ.
    Diabetes Metab Res Rev; 2004 Jan 24; 20 Suppl 2():S43-6. PubMed ID: 15551300
    [Abstract] [Full Text] [Related]

  • 37. Medically minimising the impact of hypoglycaemia in type 2 diabetes: a review.
    Noh RM, Graveling AJ, Frier BM.
    Expert Opin Pharmacother; 2011 Oct 24; 12(14):2161-75. PubMed ID: 21668402
    [Abstract] [Full Text] [Related]

  • 38. Lessons in initiating insulin in clinical practice.
    Sharma SK, Yeo JP, Garber A.
    Diabetes Res Clin Pract; 2008 Sep 24; 81 Suppl 1():S16-22. PubMed ID: 18672308
    [Abstract] [Full Text] [Related]

  • 39. Biphasic insulin aspart 30 treatment improves glycemic control among patients with type 2 diabetes in Saudi Arabia and the Gulf region.
    Ayad NM, Fattah WA, Bakry H.
    Saudi Med J; 2008 Jun 24; 29(6):919-20. PubMed ID: 18521482
    [No Abstract] [Full Text] [Related]

  • 40. Physician perception and recommendation of insulin pens for patients with type 2 diabetes mellitus.
    Peyrot M, Rubin RR.
    Curr Med Res Opin; 2008 Aug 24; 24(8):2413-22. PubMed ID: 18627641
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.